Stage-Associated Cellular and Molecular Signatures in Diabetic Retinopathy Identified Through Integrated Bulk and...

Area of Science:

• Ophthalmology
• Genomics
• Molecular Biology

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss in diabetes patients.
• The specific cellular and molecular changes in retinal cells during DR progression are not fully understood.
• Understanding these changes is crucial for developing effective treatments.

Purpose of the Study:

• To comprehensively map the cellular and molecular landscape of diabetic retinopathy (DR) across different disease stages.
• To identify key cell populations and signaling pathways involved in DR progression.
• To discover potential diagnostic biomarkers and therapeutic targets for DR.

Main Methods:

• Integration of bulk and single-cell transcriptomic data from human and mouse retinas.
• Analysis of gene expression patterns and cell-cell communication pathways.
• Validation of key gene expression changes using quantitative PCR (qPCR).

Main Results:

• Photoreceptors show altered ribosomal pathways in no-DR (NDR).
• Endothelial cells and pericytes exhibit transcriptional changes and LAMININ signaling alterations in non-proliferative DR (NPDR).
• Neural and glial cells are involved in proliferative DR (PDR), with ANGPTL signaling changes; DR-specific cell subtypes and potential gene signatures were identified.

Conclusions:

• This study provides a detailed cellular and molecular map of DR progression.
• Identified cell-specific changes and signaling pathways offer insights into DR pathogenesis.
• Findings suggest potential novel therapeutic targets and biomarkers for DR management.